"We are leading a revolution in oncology. Through our relentless quest for innovation, we have created one of the most diverse portfolios in the industry and we continue to pioneer new ways to target cancer earlier and with greater precision, for the benefit of patients."
Dr Susan Galbraith, Executive Vice President, Oncology R&D, AstraZeneca
We have
183
projects in our pipeline
